Tasimelteon

Tasimelteon

SCHEMBL7702579

CCC(=O)NC[C@@H]1C[C@@H]1c1cccc2c1CCO2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MTNR1AMTNR1B

The experimentally established mechanism targets of Tasimelteon. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MTNR1B known ✓ P49286 18/20 1.00
MTNR1A known ✓ P48039 17/20 0.56
SLC9A1 P19634 1/20 0.50
ABCB11 O95342 1/20 0.49
SIGMAR1 Q99720 1/20 0.49
USP2 O75604 1/20 0.49
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
DRD3 P35462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tasimelteon SCHEMBL3505909 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL15805072 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL15805116 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL29351713 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL17269306 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL15142113 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL23499868 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
Tasimelteon SCHEMBL3505912 1.00 MTNR1B (1.00) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
SCHEMBL6677570 0.93 MTNR1B (0.87) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1
SCHEMBL6677567 0.93 MTNR1B (0.87) MTNR1BMTNR1ASLC9A1ABCB11SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1082115-A4 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2002-10-24 EP claimed
US-6214869-B1 SLEEP DISORDERS BRISTOL-MYERS SQUIBB 2001-04-10 US claimed
EP-1082115-A1 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-03-14 EP claimed
WO-1999062515-A1 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-12-09 WO claimed
EP-1082115-A4 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL MYERS SQUIBB CO (US) 2002-10-24 EP disclosed
US-6214869-B1 SLEEP DISORDERS BRISTOL-MYERS SQUIBB 2001-04-10 US disclosed
EP-1082115-A1 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-03-14 EP disclosed
WO-1999062515-A1 HETEROCYCLIC CIS CYCLOPROPANE DERIVATIVES AS MELATONERGIC AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-12-09 WO disclosed